Sanofi (SNY) Other Non-Current Assets (2012 - 2026)

Sanofi has disclosed Other Non-Current Assets across 15 years of filings, most recently posting $5.5 billion for Q2 2026.

• In Q2 2026, Other Non-Current Assets rose 18.25% year-over-year to $5.5 billion; the TTM figure through Jun 2026 stood at $5.5 billion (up 18.25% YoY), while the FY2025 annual figure was $5.1 billion, up 25.06% from the prior year.
• Other Non-Current Assets came in at $5.5 billion for Q2 2026 at Sanofi, up from $5.1 billion in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $5.5 billion in Q2 2026 to a low of $3.2 billion in Q4 2022.
• Average Other Non-Current Assets over 5 years is $4.0 billion, with a median of $3.6 billion recorded in 2024.
• Year-over-year, Other Non-Current Assets fell 11.73% in 2022 and climbed 29.59% in 2025.
• Over 5 years, Other Non-Current Assets stood at $3.2 billion in 2022, then grew by 9.65% to $3.5 billion in 2023, then rose by 15.83% to $4.0 billion in 2024, then increased by 26.67% to $5.1 billion in 2025, then rose by 8.28% to $5.5 billion in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $5.5 billion in Q2 2026, $5.1 billion in Q4 2025, and $4.7 billion in Q2 2025.